Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters

Molecular Medicine Reports

Volumn 3, Issue 4, 2010, Pages 575-580

  Antón Aparicio, Luis M ^a,b   Villaamil, Vanessa Medina ^c   Calvo, Moisés Blanco ^c   Rubira, Luis Valbuena ^d   Rois, José Manuel ^g   Valladares Ayerbes, Manuel ^a   Campelo, Rosario García ^a   Bolós, M Victoria ^e   Pulido, Enrique Grande ^f  

^a A Coruna University Hospital   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

^c Biomedical Research Institute INIBIC   (Spain)

^d Hospital HM Modelo   (Spain)

^e PFIZER INC   (United States)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g NONE

Author keywords

Carbohydrates; Glucose transporter; Renal cell carcinoma; Tissue arrays

Indexed keywords

FRUCTOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUCOSE TRANSPORTER 5; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PELVIS; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PROTEIN EXPRESSION; RANK SUM TEST; RETROSPECTIVE STUDY; TISSUE MICROARRAY; TUMOR LOCALIZATION;

MAMMALIA;

EID: 77956707063     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000300     Document Type: Article

References (23)

1. Mathew A, Devesa SS, Fraumeni JF Jr and Chow WH: Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 11: 171-178, 2002.
2. Gupta K, Miller JD, Li JZ, Russell MW and Charbonneau C: Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 34: 193-205, 2008.
3. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M and Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592, 2007.
4. American Cancer Society. Estimated new cancer cases and deaths by sex, US, 2008. American Cancer Society: http://www.cancer.org/downloads/stt/ CFF2008Table-pg4.pdf. Accessed June, 2009.
5. Isselbacher KJ: Sugar and amino acid transport by cells in culture - differences between normal and malignant cells. N Engl J Med 286: 929-933, 1972.
6. Hatanaka M: Transport of sugars in tumor cell membranes. Biochim Biophys Acta 355: 77-104, 1974.
7. Kresnik E, Gallowitsch HJ, Mikosch P, et al: Fluorine-18- fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 133: 294-299, 2003.
8. Manolescu AR, Witkowska K, Kinnaird A, Cessford T and Cheeseman C: Facilitated hexose transporters: new perspectives on form and function. Physiology 22: 234-240, 2007.
9. Mueckler MA and Rhoads DB: Facilitative glucose transporters. Eur J Biochem 219: 713-725, 1994.
10. Schürmann A: Insight into the 'odd' hexose transporters GLUT3, GLUT5 and GLUT7. Am J Physiol Endocrinol Metab 295: 225-226, 2008.
11. Douard V and Ferraris RP: Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab 295: 227-237, 2008.
12. Cantuaria G, Fagotti A, Ferradina G, Magalhaes A, Nadji M, Angioli R, Penalver M, Mancuso S and Scambia G: GLUT-1 expression in ovarian carcinoma: association with surival and response to chemotherapy. Cancer 92: 1144-1150, 2001.
13. Rogers ES, Macheda ML, Docherty SE, Carty MD, Henderson MA, Soeller WC, Gibbs EM, James DE and Best JD: Identification of a novel glucose transporter-like protein-GLUT-12. Am J Physiol Endocrinol Metab 282: 733-738, 2002.
14. Younes M, Lechago LV, Somoano JR, Mosharaf M and Lechago J: Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer Res 17: 2747-2750, 1997.
15. Suganuma N, Segade F, Matsuzu K and Bowden DW: Differential expression of facilitative glucose transporters in normal and tumour kidney tissues. BJU Int 99: 1143-1149, 2007.
16. Lidgren A, Bergh A, Grankvist K, Rasmuson T and Ljungberg B: Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1α. BJU Int 101: 480-484, 2007.
17. Miyakita H, Tokunaga M, Onda H, Usui Y, Kinoshita H, Kawamura N and Yasuda S: Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 9: 15-18, 2002.
18. Sugawara-Yokoo M, Suzuki T, Matsuzaki T, Naruse T and Takata K: Presence of fructose transporter GLUT5 in the S3 proximal tubules in the rat kidney. Kidney Int 56: 1022-1028, 1999.
19. Corpe CP, Bovelander FJ, Munoz CM, Hoekstra JH, Simpson IA, Kwon O, Levine M and Burant CF: Cloning and functional characterization of the mouse fructose transporter, GLUT5. Biochim Biophys Acta 1576: 191-197, 2002.
20. Burant CF and Saxena M: Rapid reversible substrate regulation of fructose transporter expression in rat small intestine and kidney. Am J Physiol Gastrointest Liver Physiol 267: G71, 1994.
21. Nagase Y, Takata K, Moriyama N, Aso Y, Murakami T and Hirano H: Immunohistochemical localization of glucose transporters in human renal cell carcinoma. Br J Urol 153: 798-801, 1995.
22. Godoy A, Ulloa V, Rodriguez F, et al: Differential subcellular distribution of glucose transporters GUT1-6 and GLUT9 in human cancer: ultrastuctural localization of GLUT1 and GLUT5 inbreast tumor tissues. J Cell Physiol 270: 614-627, 2006.
23. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.